92 related articles for article (PubMed ID: 6603362)
1. Two monoclonal antibodies identifying a subset of human peripheral mononuclear cells with natural killer cell activity.
Bai Y; Beverley PC; Knowles RW; Bodmer WF
Eur J Immunol; 1983 Jul; 13(7):521-7. PubMed ID: 6603362
[TBL] [Abstract][Full Text] [Related]
2. Characterization of an antigen expressed by human natural killer cells.
Griffin JD; Hercend T; Beveridge R; Schlossman SF
J Immunol; 1983 Jun; 130(6):2947-51. PubMed ID: 6574190
[TBL] [Abstract][Full Text] [Related]
3. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1).
Abo T; Balch CM
J Immunol; 1981 Sep; 127(3):1024-9. PubMed ID: 6790607
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotypic demonstration of two natural killer surface markers, H25 and H366, on fresh human leukemic cells.
Körfer A; Kirchner H; Schneekloth C; Bührer C; Wisniewski D; Gulati S; Clarkson B; Knowles R; Poliwoda H; Atzpodien J
Acta Haematol; 1989; 82(4):193-6. PubMed ID: 2511721
[TBL] [Abstract][Full Text] [Related]
5. Malignant human B cells express two populations of p24 surface antigens.
Pesando JM; Hoffman P; Conrad T
J Immunol; 1986 Apr; 136(7):2709-14. PubMed ID: 3485154
[TBL] [Abstract][Full Text] [Related]
6. Natural suppressor (NS) cells found in the spleen of neonatal mice and adult mice given total lymphoid irradiation (TLI) express the null surface phenotype.
Oseroff A; Okada S; Strober S
J Immunol; 1984 Jan; 132(1):101-10. PubMed ID: 6228575
[TBL] [Abstract][Full Text] [Related]
7. Characterization of human granular lymphocyte subpopulations expressing HNK-1 (Leu-7) and Leu-11 antigens in the blood and lymphoid tissues from fetuses, neonates and adults.
Abo T; Miller CA; Balch CM
Eur J Immunol; 1984 Jul; 14(7):616-23. PubMed ID: 6430709
[TBL] [Abstract][Full Text] [Related]
8. Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice.
Christianson SW; Greiner DL; Schweitzer IB; Gott B; Beamer GL; Schweitzer PA; Hesselton RM; Shultz LD
Cell Immunol; 1996 Aug; 171(2):186-99. PubMed ID: 8806787
[TBL] [Abstract][Full Text] [Related]
9. A subset of human cells isolated and characterized by monoclonal antibodies.
Lohmeyer J; Rieber P; Feucht H; Johnson J; Hadam M; Riethmüller G
Eur J Immunol; 1981 Dec; 11(12):997-1001. PubMed ID: 7035187
[TBL] [Abstract][Full Text] [Related]
10. A monoclonal antibody (VEP10) against an antigen shared by human large granular lymphocytes, thymocytes and activated T cells.
Rumpold H; Kraft D; Obexer G; Böck G; Möschl P
Immunology; 1983 Jun; 49(2):265-72. PubMed ID: 6602090
[TBL] [Abstract][Full Text] [Related]
11. Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cells.
van de Griend RJ; van Krimpen BA; Ronteltap CP; Bolhuis RL
J Immunol; 1984 Jun; 132(6):3185-91. PubMed ID: 6233369
[TBL] [Abstract][Full Text] [Related]
12. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation.
Ferrini S; Cantoni C; Ciccone E; Biassoni R; Prigione I; Bottino C; Venzano P; Moretta L
Eur J Immunol; 1991 Sep; 21(9):1981-7. PubMed ID: 1832383
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes.
Wang CY; Azzo W; Al-Katib A; Chiorazzi N; Knowles DM
J Immunol; 1984 Aug; 133(2):684-91. PubMed ID: 6429242
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein antigenicity on the surface of human peripheral blood lymphocytes. Characterization of lymphocytes reactive with anti-neo-CRP.
Bray RA; Samberg NL; Gewurz H; Potempa LA; Landay AL
J Immunol; 1988 Jun; 140(12):4271-8. PubMed ID: 2453575
[TBL] [Abstract][Full Text] [Related]
15. TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells).
Yodoi J; Teshigawara K; Nikaido T; Fukui K; Noma T; Honjo T; Takigawa M; Sasaki M; Minato N; Tsudo M
J Immunol; 1985 Mar; 134(3):1623-30. PubMed ID: 2578514
[TBL] [Abstract][Full Text] [Related]
16. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
17. A study of GRM1 monoclonal antibody that reacts with natural killer cells and granulocytes.
Ruiz-Cabello F; López Nevot MA; Garrido A; Garrido F
Nat Immun Cell Growth Regul; 1987; 6(2):99-108. PubMed ID: 2439907
[TBL] [Abstract][Full Text] [Related]
18. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
19. In vitro generation of NK-like activity in human PBL co-cultured with fresh T leukaemia cells.
Matera L; Foa R; Moore M
J Clin Lab Immunol; 1984 Oct; 15(2):85-90. PubMed ID: 6335181
[TBL] [Abstract][Full Text] [Related]
20. Both Fc receptors and lymphocyte-function-associated antigen 1 on human T gamma lymphocytes are required for antibody-dependent cellular cytotoxicity (killer cell activity).
Miedema F; Tetteroo PA; Hesselink WG; Werner G; Spits H; Melief CJ
Eur J Immunol; 1984 Jun; 14(6):518-23. PubMed ID: 6610556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
